Turik M A, Markowitz S M
Division of Infectious Disease, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0049.
J Heart Lung Transplant. 1992 Jul-Aug;11(4 Pt 1):781-3.
We report a case involving orthotopic heart transplantation in which a recipient, known to be serologically negative for hepatitis B virus infection, received a heart from a donor known before transplantation to be hepatitis B surface antigen positive. The recipient was treated prospectively with a combination of hepatitis B immune globulin and hepatitis B vaccine. After 10 months of follow-up, the recipient has not experienced seroconversion or viremia from hepatitis B virus and has remained without symptoms by both clinical and laboratory measurements.
我们报告了一例原位心脏移植病例，该病例中，一名已知乙肝病毒感染血清学检测呈阴性的受者接受了一颗来自移植前已知乙肝表面抗原呈阳性供者的心脏。对该受者前瞻性地采用了乙肝免疫球蛋白和乙肝疫苗联合治疗。经过10个月的随访，该受者未出现乙肝病毒血清学转换或病毒血症，临床和实验室检查均未出现症状。
